Skip to main content
Log in

Chagas disease screening cost effective in Latin Americans in EU

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • , et al. Chagas disease screening cost effective in Latin Americans in EU PharmacoEconomics and Outcomes News : No. 773, 11 Mar 2017

  • Requena-Mendez A, et al. Cost-effectiveness of Chagas disease screening in Latin American migrants at primary health-care centres in Europe: a Markov model analysis. The Lancet Global Health : 28 Feb 2017. Available from: URL: http://dx.doi.org/10.1016/S2214-109X(17)30073-6

  • Castillo-Riquelme M. Chagas disease in non-endemic countries. The Lancet Global Health : 28 Feb 2017. Available from: URL: http://dx.doi.org/10.1016/S2214-109X(17)30090-6

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chagas disease screening cost effective in Latin Americans in EU. PharmacoEcon Outcomes News 773, 13 (2017). https://doi.org/10.1007/s40274-017-3798-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-3798-x

Navigation